KRAS mutation-negative colorectal cancer is also commonly known as KRAS wild-type. Concurrently, the FDA has also approved the first KRAS companion diagnostic test, the therascreen KRAS diagnostic kit
The filing is made under an Orphan Drug Designation for the indication cryopyrin associated periodic syndromes (CAPS), which was granted in 2010. Sobi said it expects a review
ShangPharma chairman, chief executive officer and founder Michael Xin Hui and TPG Star Charisma have sent a non-binding proposal to ShangPharma’s Board of Directors to acquire all of
Lemke, with over 20 years of experience in critical financial reporting and management positions, succeeds Anthony Chilton, who has resigned as CEO to pursue other opportunities. Bioanalytical Systems
As part of the approval, Lilly has gained an additional six months of US market exclusivity for Cymbalta, which now will expire in December 2013. The approval of
While not accepting the claims of R-Tech Ueno, the arbitral award said the supply agreement among R-Tech Ueno, Takeda and Sucampo executed in 2004 regarding the exclusive supply
The multicenter, multinational, partially randomized, open-label trial includes 120 to 140 previously treated subjects (PTP). The PROTECT VIII (PROphylaxis in hemophilia A patienTs via directly pEgylated long-aCTing rFVIII)
Under the terms of the agreement, Merck will obtain the rights to use the technology with two investigational antigen-specific cancer immunotherapies which are in pre-clinical development. PDS Biotechnology
Led by Edward Lin,a medical oncologist at the University of Washington and his collaborators, the study will be the first to specifically target colon cancer stem cells. The
ADCs will be developed using CRT antibodies and peptides and ADCT’s ‘ warhead’ and linker chemistries. As part of the development programme, ADCT will grant funds for preclinical
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.